99 related articles for article (PubMed ID: 2111468)
21. Changing patterns of microbial contamination and antimicrobial sensitivity in donor eyes.
Satpathy G; Angra SK
Ann Ophthalmol; 1993 Dec; 25(12):442-6. PubMed ID: 8129326
[TBL] [Abstract][Full Text] [Related]
22. Oral-disease prevention in children with cancer: testing preventive protocol effectiveness.
Rojas de Morales T; Zambrano O; Rivera L; Navas R; Chaparro N; Bernardonni C; Rivera F; Fonseca N; Tirado DM
Med Oral; 2001; 6(5):326-34. PubMed ID: 11694865
[TBL] [Abstract][Full Text] [Related]
23. Bacterial contamination of autologous bone marrow: reinfusion of culture-positive grafts does not result in clinical sequelae during the posttransplantation course.
Schwella N; Rick O; Heuft HG; Miksits K; Zimmermann R; Zingsem J; Eckstein R; Huhn D
Vox Sang; 1998; 74(2):88-94. PubMed ID: 9501406
[TBL] [Abstract][Full Text] [Related]
24. Oral complications of cancer therapy.
Redding SW
Tex Med; 2003 May; 99(5):54-7. PubMed ID: 12772642
[TBL] [Abstract][Full Text] [Related]
25. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.
Weber SG; Huang SS; Oriola S; Huskins WC; Noskin GA; Harriman K; Olmsted RN; Bonten M; Lundstrom T; Climo MW; Roghmann MC; Murphy CL; Karchmer TB
Am J Infect Control; 2007 Mar; 35(2):73-85. PubMed ID: 17327185
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.
Depuydt PO; Blot SI; Benoit DD; Claeys GW; Verschraegen GL; Vandewoude KH; Vogelaers DP; Decruyenaere JM; Colardyn FA
Crit Care Med; 2006 Mar; 34(3):653-9. PubMed ID: 16505649
[TBL] [Abstract][Full Text] [Related]
27. The changing pattern of bloodstream infection in pediatric oncology patients in the United Arab Emirates.
Trad O; Jumaa PA; Afify Z
Pediatr Hematol Oncol; 2003 Jun; 20(4):281-9. PubMed ID: 12746160
[TBL] [Abstract][Full Text] [Related]
28. [Standards, Options and Recommendations (SOR) for the surveillance and the prevention of cross infections in oncology. Fédération Nationale des Centres de Lutte Contre le Cancer].
Pottecher B; Herbrecht R; Blanc-Vincent MP; Bussy Malgrange V; Escande MC; Fuhrmann C; Crokaert F; Gory-Delabaere G; Senet JM; Lesimple T; Raveneau J; Béal J; Biron P; Viot M
Bull Cancer; 2000 Jul; 87(7-8):557-91. PubMed ID: 10969214
[TBL] [Abstract][Full Text] [Related]
29. Healthcare epidemiology: active surveillance cultures and contact precautions for control of multidrug-resistant organisms: ethical considerations.
Santos RP; Mayo TW; Siegel JD
Clin Infect Dis; 2008 Jul; 47(1):110-6. PubMed ID: 18491966
[TBL] [Abstract][Full Text] [Related]
30. [Microbiologic findings in nephrology].
Mittermayer H
Wien Med Wochenschr; 1986 Jan; 136(1-2):7-10. PubMed ID: 3515774
[TBL] [Abstract][Full Text] [Related]
31. [Selection of appropriate antimicrobial agents to test and report by clinical microbiology laboratories].
Koibuchi H; Shibuya Y; Kubo N; Kawano M; Itoh K
Rinsho Byori; 2002 Oct; 50(10):992-9. PubMed ID: 12451681
[TBL] [Abstract][Full Text] [Related]
32. [Laboratory control in diagnosis and treatment of infective endocarditis].
Pascual A; Perea EJ
Rev Esp Cardiol; 1998; 51 Suppl 2():22-8. PubMed ID: 9658945
[TBL] [Abstract][Full Text] [Related]
33. Risk factors and causative organisms in microbial keratitis.
Green M; Apel A; Stapleton F
Cornea; 2008 Jan; 27(1):22-7. PubMed ID: 18245962
[TBL] [Abstract][Full Text] [Related]
34. Microbial study of hospital environment and carrier pattern study among staff in Nepal Medical College Teaching Hospital.
Pant J; Rai SK; Singh A; Lekhak B; Shakya B; Ghimire G
Nepal Med Coll J; 2006 Sep; 8(3):194-9. PubMed ID: 17203829
[TBL] [Abstract][Full Text] [Related]
35. Microbiology of community-acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection. Implications for rational empiric antibiotic therapy.
Burack JH; Hahn JA; Saint-Maurice D; Jacobson MA
Arch Intern Med; 1994 Nov; 154(22):2589-96. PubMed ID: 7979856
[TBL] [Abstract][Full Text] [Related]
36. Febrile neutropenia. Etiology of infection, empirical treatment and prophylaxis.
Eltahawy AT
Saudi Med J; 2003 Apr; 24(4):331-6. PubMed ID: 12754528
[TBL] [Abstract][Full Text] [Related]
37. The value of surveillance cultures in neutropenic patients receiving selective intestinal decontamination.
de Jong PJ; de Jong MD; Kuijper EJ; van der Lelie H
Scand J Infect Dis; 1993; 25(1):107-13. PubMed ID: 8460334
[TBL] [Abstract][Full Text] [Related]
38. Oral health in cancer therapy: evaluating and preventing oral complications.
Rankin KV
Dent Today; 2000 Sep; 19(9):60-5. PubMed ID: 12524728
[No Abstract] [Full Text] [Related]
39. Oropharyngeal Candida prophylaxis in pediatric bone marrow transplant patients.
Berkowitz RJ; Hughes C; Rudnick M; Gordon EM; Strandjord S; Cheung NK; Warkentin P; Coccia PF
Am J Pediatr Hematol Oncol; 1985; 7(1):82-6. PubMed ID: 3898901
[TBL] [Abstract][Full Text] [Related]
40. Transplantation: the role of microbiologic services.
Bovey SH; Clancy MC; Colonna PJ
Clin Lab Sci; 1990; 3(5):320-3. PubMed ID: 10149031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
